Speaker Profile
PMWC LUMINARY AWARD
Catalyzed the billion-cell, AI-powered leap in single-cell and spatial biology, turning massive cell atlases into predictive models that push precision medicine toward the clinic
M.D., Co-Founder and Co-CEO, Chan Zuckerberg Initiative
Biography
Priscilla Chan is the co-founder and co-CEO of the Chan Zuckerberg Initiative, where she leads efforts to advance biomedical research and technology to help scientists cure, prevent, or manage all disease by the end of this century. As a pediatrician, her firsthand experience caring for patients has fueled her commitment to accelerating scientific discovery. Priscillas leadership at CZI has focused on harnessing AI, building cutting-edge research tools, and funding innovative science to unlock new insights into human biology. She earned her bachelors degree in biology from Harvard University and her doctor of medicine from the University of California, San Francisco, where she also completed her pediatrics residency.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Christina Curtis, Stanford
PMWC Award Ceremony Honoree
• W.E. Moerner, Stanford – Nobel Laureate
• Priscilla Chan, Co-Founder & Co-CEO, Chan Zuckerberg Initiative
• Serge Saxonov, 10x Genomics
Fireside Chat
• Moderator: Christina Curtis, Stanford
• W.E. Moerner, Stanford
• Priscilla Chan, Chan Zuckerberg Initiative
Fireside Chat with Serge Saxonov, 10x Genomics
Unraveling Tissue Architecture with Single-Cell & Spatial Multi-Omics
• Joakim Lundeberg, SciLifeLab
• Garry P. Nolan, Stanford
• Tae Hyun Hwang, Vanderbilt University Medical Center
Tumor Evolution & Clonal Dynamics: From Models to Monitoring
• Chair: Christina Curtis, Stanford
Multi-Omics-Driven Early Detection: Beyond Liquid Biopsy
• Ash Alizadeh, Stanford
• Alex Aravanis, Moonwalk Biosciences
Personal Omics at Scale: What Longitudinal Profiles Add to Early Detection
• Michael Snyder, Stanford
AI in Molecular Diagnostics: Integrating Multi-Omics & Clinical Data
• Chair: Marina Sirota, UCSF
• Olivier Gevaert, Stanford
• Rebecca Critchley-Thorne, Castle Biosciences
Nanomechanical Signatures for Cancer Diagnostics: Insights from Tumor Biophysics
• Chair: Marija Plodinec, Artidis
